Biomapas Logo

The Perfect Partnership:

How Mid-Sized CROs and Site Networks Deliver Clinical Trial Success

Balancing agility and reach, while ensuring operational efficiency and patient-centricity, is no straightforward task in clinical trials. One key enabler in achieving this balance? Finding the right partners – CROs and sites.  

Right size of the CROs and right type of the site network working together as partners are able to deliver the clinical trial success through more structured and collaborative approach. From established global site networks like Pratia to growing Site Management Organisations (SMOs) in emerging markets such as Medrial in Armenia, these partnerships are reshaping how CROs and Sponsors approach feasibility, site selection, and geographic diversity. 

This webinar brings together expert voices from across these key players in clinical research to discuss how such partnerships are evolving into tailored, strategic collaborations, and how they can help sponsors – pharmaceutical and biotech companies deliver clinical trial success. Whether navigating early-phase oncology studies or scaling large multinational trials, we will examine how aligned goals, specialised expertise and patient-focused models are driving results. 

 

 

Register for the panel discussion to explore:

  • How mid-sized CROs partner with site networks to accelerate operations, optimize the costs and reach patients. 
  • What are the benefits of modern site networks, and the specialised clinical expertise they offer. 
  • The growing value of SMOs in emerging markets like Armenia, and how they enable trial collaboration and patient access. 
  • Real-world insights from a Phase I oncology study run within a site network, including takeaways on feasibility and patient voice.
  • Why biotech sponsors should re-evaluate their assumptions about site networks from early to late-phase trials.

The Panelists

Chloe Rose, Ph.D.

Executive Director of Portfolio Management, Pratia

Chloe Rose joined Pratia in 2021 as Global Portfolio Lead and was promoted to Executive Director of Portfolio Management within two years. She oversees Global Feasibility & Proposals, Budget & Contract Negotiations, Early Phase Portfolio, and Global Client Relationship Management. Previously, she worked at a global pharmaceutical company as a European and then Global Clinical Trial Manager, where she led strategic operations and supported business acquisitions to enhance efficiency. Chloe is passionate about accelerating access to innovative treatments for patients. She holds a PhD in Bioengineering and a BSc in Pharmacology from the University of Southampton, UK.

Dr Santiago Viteri

Medical Director, Pratia Sirius

Dr. Santiago Viteri is a medical oncologist with a degree from the University of Navarra. He began his career at Mateu Orfila Hospital in Menorca, later joining the Dr. Rosell Oncology Institute (2008–2021), where he specialised in molecular biology, personalised medicine, and thoracic tumors. As Clinical Director from 2011, he led a team of 14 oncologists across four hospitals in Barcelona. Since 2021, he has served as Medical Director at UOMI Cancer Centre, focusing on holistic cancer care. In 2024, he became Principal Investigator and Acting CEO of Pratia Sirius, a clinical research unit. By January 2025, he had led over 40 studies as PI and contributed to more than 20 as Sub-Investigator.

Garegin Khanazadyan

Chief Executive Officer, Medrial LLC  

Garegin Khanazadyan is the CEO of Medrial LLC, a site management organization based in Yerevan, Armenia. Since 2022, he has led the company’s strategic development, focusing on clinical trial management and regulatory affairs. He holds degrees in finance and international management from the French University in Armenia and Jean Moulin Lyon 3 University. Garegin brings over a decade of experience in regulatory affairs, external relations, and study management coordination. Early in his career, he gained hands-on experience through internships at a local medical center, contributing to his strong grasp of Armenia’s clinical research environment.

Artūras Pažėra

Senior Project Manager in Clinical Research, Biomapas

Arturas Pazera is a Senior Project Manager at Biomapas, where he has led clinical research initiatives since 2019. With over two decades of experience, Arturas has held leadership roles, including Project Leader and Senior Clinical Operations Leader, overseeing complex international trials, cross-functional teams, and global project delivery. His expertise spans project implementation, budgeting, TMF management, and client relations. Known for driving operational excellence and team performance, Arturas is committed to ensuring high-quality, compliant clinical trials that meet timelines and strategic goals.

The Host

Denitza Christova

Associate Director Business Development, Biomapas  

Denitza Christova is Associate Director BD at Biomapas, where she leads business development initiatives to expand global collaborations in clinical research. With over a decade in the life sciences sector, she brings deep expertise in pharmacovigilance, client relations, and strategic growth. Deni has held key roles as Local QPPV and Manager of Safety Operations, as well as leadership positions in clinical operations and medical information. She is dedicated to advancing partnerships that drive innovative healthcare solutions.

Big Enough To Cover  All Your Needs. Small Enough To Care.

Discover the tailored solutions that Biomapas provides to accelerate your clinical trials and optimize your drug development process.

Clinical Research

Regulatory Affairs

Pharmacovigilance

Medical Information